cloricromen has been researched along with warfarin in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (88.89) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costantini, V; Goracci, G; Nenci, GG; Pistolesi, R; Porcellati, S; Prosdocimi, M; Stasi, M | 1 |
| Bertocchi, F; Breviario, F; Dejana, E; Ghezzi, P; Prosdocimi, M; Proserpio, P; Travagli, RA; Wang, JM | 1 |
| Banzatto, N; Finesso, M; Mariot, R; Prosdocimi, M; Tessari, F; Travagli, RA; Zatta, A | 1 |
| Altavilla, D; Caputi, AP; Prosdocimi, M; Squadrito, F; Sturniolo, R; Trimarchi, GR | 1 |
| Falasca, A; Fiorentini, D; Hakim, G; Prosdocimi, M; Rossi, CA | 1 |
| Bertazzo, A; Colombo, C; Galli, C; Petroni, A; Sarti, S | 1 |
| Dal Bo Zanon, R; Fabris, F; Girolami, A; Luzzatto, G | 1 |
| Dejana, E; Prosdocimi, M; Zanetti, A; Zatta, A | 1 |
| Bianciardi, G; Di Perri, T; Franchi, M; Martelli, G; Toti, P; Vittoria, A; Weber, G | 1 |
| Dejana, E; Gorio, A; Prosdocimi, M; Zanetti, A; Zatta, A | 1 |
| Costantini, V; Goracci, G; Nenci, GG; Pistolesi, R; Porcellati, S; Porrovecchio, P; Prosdocimi, M | 1 |
| Bianciardi, G; Massari, P; Orlando, P; Toti, P; Weber, G | 1 |
| Aporti, F; Bertolino, M; Finesso, M; Gorio, A; Prosdocimi, M | 1 |
| de Gaetano, G; Dejana, E; Finesso, M; Gorio, A; Languino, LR; Prosdocimi, M; Tessari, F | 1 |
| Balconi, G; de Castellarnau, C; de Gaetano, G; Dejana, E; Pietra, A; Rotilio, D | 1 |
| Colli, S; Colombo, C; Galli, C; Petroni, A; Socini, A | 1 |
| Agradi, E; Galli, C; Petroni, A; Socini, A | 1 |
| Castellano, VP; Galaska, HJ; Kim, EJ; Murphy, BA; Royster, RL; Vinten-Johansen, J; Williams, MW; Zvara, DA | 1 |
18 other study(ies) available for cloricromen and warfarin
| Article | Year |
|---|---|
The coumarin derivative AD6 inhibits the release of arachidonic acid by interfering with phospholipase A2 activity in human platelets stimulated with thrombin.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Chromonar; Coumarins; Diglycerides; Humans; Inositol; Phosphatidylcholines; Phosphatidylinositols; Phospholipases; Phospholipases A; Phospholipases A2; Phospholipids; Plasmalogens; Thrombin | 1990 |
In vitro inhibition of human polymorphonuclear cell function by cloricromene.
Topics: Cell Adhesion; Cell Survival; Chemotaxis, Leukocyte; Chromium Radioisotopes; Chromonar; Coumarins; Endothelium, Vascular; Fibrinolytic Agents; Humans; In Vitro Techniques; Interleukin-1; Leukocyte Adherence Inhibition Test; Neutrophils; Superoxides; Time Factors; Vasodilator Agents | 1989 |
Molecular aspects of cloricromene (AD6) distribution in human platelets and its pharmacological effects.
Topics: Adenosine Diphosphate; Blood Platelets; Chemical Phenomena; Chemistry; Chromonar; Coumarins; Female; Humans; In Vitro Techniques; Male; Platelet Aggregation Inhibitors | 1989 |
Cloricromene improves survival rate and peritoneal macrophage function in splanchnic artery occlusion shock in rats.
Topics: Animals; Chromonar; Coumarins; Dose-Response Relationship, Drug; In Vitro Techniques; Macrophage Activation; Male; Peritoneal Cavity; Rats; Rats, Inbred Strains; Shock; Thromboxane B2 | 1989 |
Effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonylme tho xy coumarin) on cyclic nucleotide phosphodiesterases in human platelets.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Blood Platelets; Chromonar; Coumarins; Humans; Nucleotides, Cyclic; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases | 1988 |
The carbochromene derivative AD6 reduces the TxB2/6-keto-PGF1 alpha ratio in cerebral cortex during hypoxia and recovery and leukotriene synthesis in brain tissue, in the rat.
Topics: 6-Ketoprostaglandin F1 alpha; Anaerobiosis; Animals; Cerebral Cortex; Chromonar; Coumarins; Hypoxia; In Vitro Techniques; Kinetics; Leukotriene B4; Lipoxygenase; Male; Rats; Rats, Inbred Strains; SRS-A; Thromboxane B2 | 1988 |
Lack of antiplatelet activity of the new coumarin derivative 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy- carboxylmethoxycoumarin under in vivo conditions in man.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; beta-Thromboglobulin; Blood Platelets; Chromonar; Collagen; Coumarins; Humans; In Vitro Techniques; Platelet Aggregation | 1986 |
The effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy- carbonylmethoxycoumarin) on washed human platelet aggregation induced by platelet activating factor (PAF) and epinephrine.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Aspirin; beta-Thromboglobulin; Blood Platelets; Chromonar; Coumarins; Drug Interactions; Epinephrine; Humans; In Vitro Techniques; Masoprocol; Platelet Activating Factor; Platelet Aggregation; Pyrazoles | 1986 |
Ultrastructural modifications of the platelet plasma membrane in vascular diseases and the effect of a carbochromen derivative as studied by freeze-fracture and computer measurement.
Topics: Administration, Oral; Adult; Aged; beta-Thromboglobulin; Blood Platelets; Cell Membrane; Chromonar; Computers; Coumarins; Female; Freeze Etching; Humans; Male; Middle Aged; Surface Properties; Vascular Diseases | 1986 |
Action of AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmet hox y coumarin) on human platelets in vitro.
Topics: Anticoagulants; beta-Thromboglobulin; Blood Platelets; Blood Proteins; Chromonar; Coumarins; Cyclic AMP; Female; Humans; In Vitro Techniques; Male; Platelet Aggregation; Platelet Factor 4; Theophylline; Thromboxane B2 | 1986 |
AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonyl-meth oxy coumarin) inhibits the release of arachidonic acid in human platelets stimulated by thrombin.
Topics: Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Chromonar; Coumarins; Diglycerides; Dose-Response Relationship, Drug; Humans; Phospholipids; Platelet Aggregation; Radioisotopes; Thrombin; Thromboxane B2 | 1987 |
Observations on the effects of some antiaggregating drugs on platelet specific protein discharge after a very weak stimulus.
Topics: Aminophylline; Aspirin; beta-Thromboglobulin; Blood Platelets; Cell Survival; Chromonar; Coumarins; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Factor 4; Platelet-Derived Growth Factor | 1985 |
The action of AD6 on experimental arrhythmias and on action potentials of cardiac fibers.
Topics: Aconitine; Action Potentials; Animals; Arrhythmias, Cardiac; Cats; Chromonar; Coumarins; Epinephrine; Guinea Pigs; Heart Atria; In Vitro Techniques; Male; Myocardial Contraction; Rats; Rats, Inbred Strains; Sinoatrial Node | 1986 |
Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Animals; Chromonar; Collagen; Coronary Disease; Coumarins; Disease Models, Animal; Dogs; Epinephrine; Male; Platelet Activating Factor; Platelet Aggregation; Regional Blood Flow; Thromboxane B2 | 1985 |
AD 6, a coronary dilating agent, stimulates PGI2 production in rat aorta ex vivo and in human endothelial cells in culture.
Topics: Animals; Aorta, Thoracic; Cells, Cultured; Chromonar; Coumarins; Endothelium; Epoprostenol; Female; Humans; Male; Pregnancy; Prostaglandins; Rats; Umbilical Veins; Vasodilation | 1982 |
Effects of the coumarin derivative AD6 on platelet aggregation, platelet vessel wall interactions and 6 keto PGF1 alpha production in perfused aortas, in experimentally hypercholesterolaemic rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Aorta, Thoracic; Blood Platelets; Blood Vessels; Cholesterol; Chromonar; Coumarins; Epoprostenol; Hypercholesterolemia; In Vitro Techniques; Male; Platelet Aggregation; Rabbits; Thromboxane B2 | 1982 |
Effects of 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy carboxyl methoxy coumarin (AD6) on aggregation, arachidonic acid metabolism and thromboxane B2 formation in human platelets.
Topics: Adenosine Diphosphate; Arachidonic Acids; Blood Platelets; Chromonar; Collagen; Coumarins; Humans; In Vitro Techniques; Platelet Aggregation; Thromboxane B2 | 1980 |
Cloricromene reduces myocardial infarct size in rabbits when administered during the early reperfusion period.
Topics: Animals; Anticoagulants; Blood Pressure; Chromonar; Coumarins; Heart Rate; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Rabbits; Time Factors | 1997 |